Molecular Subtypes and Prognosis in Young Mexican Women With Breast Cancer

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Clinical Breast Cancer

• Publication date

  2017-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.clbc.2016.11.007PMID 28065398
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• National and regional breast cancer incidence and mortality trends in Mexico 2001-2011: Analysis of a population-based database.

  2016cited by this paper
• Absolute Benefit of Adjuvant Endocrine Therapies for Premenopausal Women With Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer: TEXT and SOFT Trials.

  2016cited by this paper
• Prevalence and Prognostic Role of BRCA1/2 Variants in Unselected Chinese Breast Cancer Patients

  2016cited by this paper
• Impact of breast cancer subtypes and patterns of metastasis on outcome

  2015cited by this paper
• US breast cancer mortality trends in young women according to race

  2015cited by this paper
• The Value of Ki67 in Very Young Women with Hormone Receptor-Positive Breast Cancer: Retrospective Analysis of 9,321 Korean Women

  2015cited by this paper
• Breast cancer age at diagnosis patterns in four Latin American Populations: A comparison with North American countries.

  2015cited by this paper
• Luminal B subtype: A key factor for the worse prognosis of young breast cancer patients in China

  2015cited by this paper
• Cancer statistics for Hispanics/Latinos, 2015

  2015cited by this paper
• Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update.

  2014cited by this paper
• Higher incidence of premenopausal breast cancer in less developed countries; myth or truth?

  2014cited by this paper
• Breast cancer presentation and diagnostic delays in young women

  2014cited by this paper
• Breast cancer in adolescent and young adult women.

  2014cited by this paper
• Biology of breast cancer in young women

  2014cited by this paper
• Breast cancer in young women in Latin America: an unmet, growing burden.

  2013cited by this paper
• Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update.

  2013cited by this paper
• Ten-year survival in patients with BRCA1-negative and BRCA1-positive breast cancer.

  2013cited by this paper
• Prospective observational study of breast cancer treatment outcomes for UK women aged 18-40 years at diagnosis: the POSH study.

  2013cited by this paper
• Impact of breast cancer subtypes on 3-year survival among adolescent and young adult women

  2013cited by this paper
• Breast cancer in Mexico: a growing challenge to health and the health system.

  2012cited by this paper
• Pathologic features and molecular phenotype by patient age in a large cohort of young women with breast cancer

  2012cited by this paper
• A Review of Cancer in U.S. Hispanic Populations

  2012cited by this paper
• Interobserver agreement among pathologists for semiquantitative hormone receptor scoring in breast carcinoma.

  2012cited by this paper
• Clinicopathologic, molecular subtype, and survival prognostic features in premenopausal breast cancer patients by age at diagnosis.

  2010cited by this paper
• American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer (unabridged version).

  2010cited by this paper
• American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer.

  2010cited by this paper
• Prognosis and adjuvant treatment effects in selected breast cancer subtypes of very young women (<35 years) with operable breast cancer.

  2010cited by this paper
• Breast Cancer in Low- and Middle-Income Countries: An Emerging and Challenging Epidemic

  2010cited by this paper
• Breast Cancer in Young Women: Poor Survival Despite Intensive Treatment

  2009cited by this paper
• Elevated breast cancer mortality in women younger than age 40 years compared with older women is attributed to poorer survival in early-stage disease.

  2009cited by this paper
• Relationship between age at diagnosis and outcome of premenopausal breast cancer: age less than 35 years is a reasonable cut-off for defining young age-onset breast cancer

  2009cited by this paper
• Patient and tumor characteristics associated with increased mortality in young women (≤40 years) with breast cancer

  2009cited by this paper
• American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer.

  2006cited by this paper
• The changing global patterns of female breast cancer incidence and mortality

  2004cited by this paper
• Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer.

  2003cited by this paper
• Young age as an independent adverse prognostic factor in premenopausal patients with breast cancer.

  2002cited by this paper
• Relationship of patient age to pathologic features of the tumor and prognosis for patients with stage I or II breast cancer.

  1994cited by this paper

• Integrated Prognostic Model for Young Breast Cancer Patients: Insights from SEER, METABRIC, and TCGA Databases.

  2025cites this paper
• Genomic Risk Evaluation Using Oncotype DX in Young Women (Aged ≤40) With Early-stage, ER-positive, Human Epidermal Growth Factor Receptor 2-negative, and Node-negative Breast Cancer

  2025cites this paper
• Androgen Receptor and Tumor-Associated Neutrophil Expression Across Breast Cancer Subtypes: Associations With Clinicopathological Characteristics

  2025cites this paper
• Hormone Receptor Positive Breast Cancer in Young Women: A Review

  2024cites this paper
• Diet quality indices are associated with breast cancer by molecular subtypes in Mexican women

  2024cites this paper
• The Expression Profiles of lncRNAs Are Associated with Neoadjuvant Chemotherapy Resistance in Locally Advanced, Luminal B-Type Breast Cancer

  2024cites this paper
• Comparison of clinicopathological and prognostic features of breast cancer patients younger than 40 years and older than 65 years

  2024influential citation
• Somatic Mutations in Latin American Breast Cancer Patients: A Systematic Review and Meta-Analysis

  2024cites this paper
• Immunohistochemical subtype and its relationship with 5-year overall survival in breast cancer patients

  2023cites this paper
• Deregulated miRNA Expression in Triple-Negative Breast Cancer of Ancestral Genomic-Characterized Latina Patients

  2023cites this paper
• Is using the Gail model to calculate the risk of breast cancer in the Venezuelan population justified?

  2023cites this paper
• Breast cancer survival in Mexico between 2007 and 2016 in women without social security: a retrospective cohort study

  2023cites this paper
• Lifestyle Quality Indices and Female Breast Cancer Risk: A Systematic Review and Meta-Analysis

  2023cites this paper
• Asociando factores pronósticos con resultados clínicos en cáncer de mama localmente avanzado

  2023cites this paper
• Understanding system barriers and facilitators in transnational clinical cancer research: The value of rapid and multimodal ethnographic inquiry

  2022cites this paper
• Mammography Stages Adoption and Health Beliefs in Mexican Women

  2022cites this paper
• Tumor characteristics, therapy, and prognosis in young breast cancer patients ≤ 35 years

  2022cites this paper
• Effects of clinicopathological factors on prognosis of young patients with resected breast cancer

  2021cites this paper
• Comprehensive omic characterization of breast cancer in Mexican-Hispanic women

  2021cites this paper
• Adherence to Adjuvant Tamoxifen in Mexican Young Women with Breast Cancer

  2021cites this paper
• Adjuvant endocrine therapy for premenopausal women with breast cancer: Patient adherence and physician prescribing practices in Mexico

  2021cites this paper
• Prospective Study of Fertility Preservation in Young Women With Breast Cancer in Mexico.

  2021cites this paper
• Unique challenges and outcomes of young women with breast cancers from a tertiary care cancer centre in India

  2021cites this paper
• Young Women with Breast Cancer in Resource-Limited Settings: What We Know and What We Need to Do Better

  2021cites this paper
• BCTT_A_303047 641..650

  2021cites this paper
• PPA_A_296747 1039..1049

  2021cites this paper
• Loco-regional recurrence trend and prognosis in young women with breast cancer according to molecular subtypes: analysis of 1099 cases

  2020cites this paper
• Young Women With Breast Cancer in Mexico: Results of the Pilot Phase of the Joven & Fuerte Prospective Cohort

  2020cites this paper
• PREVALENCE AND CHARACTERISTICS OF BREAST CANCER IN YOUNG WOMEN

  2020cites this paper
• Physicians' Attitudes, Knowledge, and Perceived Barriers toward Fertility Preservation in Young Breast Cancer Patients in a Developing Country.

  2020cites this paper
• CYP2D6 does not impact on breast cancer-free survival in Southeast Mexican patients under tamoxifen treatment.

  2020cites this paper
• Unveiling functional heterogeneity in breast cancer multicellular tumor spheroids through single-cell RNA-seq

  2020cites this paper
• Clinical utility of genomic signatures in young breast cancer patients: a systematic review

  2020cites this paper
• Clinically Relevant Germline Mutations in a Cohort of Young Women with Breast Cancer: A Comprehensive Analysis of Hereditary-Cancer Genes from Whole-Exome Sequencing

  2020cites this paper
• Caracterização clonal de linhagens celulares de câncer de mama e sua implicação em modelos experimentais para estudos in vitro

  2020cites this paper
• Locally advanced breast cancer in young women in Latin America

  2019cites this paper
• Medical and information needs among young women with breast cancer in Mexico.

  2019cites this paper
• Impact of invasive lobular carcinoma on long-term outcomes in Mexican breast cancer patients

  2019cites this paper
• Breast Cancer in Very Young Patients in a Spanish Cohort: Age as an Independent Bad Prognostic Indicator

  2019cites this paper
• Advanced Stage at Diagnosis and Worse Clinicopathologic Features in Young Women with Breast Cancer in Brazil: A Subanalysis of the AMAZONA III Study (GBECAM 0115)

  2019influential citation
• Breast Cancer in Young Women: Status Quo and Advanced Disease Management by a Predictive, Preventive, and Personalized Approach

  2019cites this paper
• Integrated copy number and miRNA expression analysis in triple negative breast cancer of Latin American patients

  2019cites this paper
• Psychosocial needs of young breast cancer survivors in Mexico City, Mexico

  2018cites this paper
• How do age and molecular subtypes impact surgical decisions

  2018cites this paper
• Mujeres Jóvenes con Cáncer de Mama: Necesidades de Apoyo en Atención y Resiliencia

  2018cites this paper
• Effects of clinicopathological factors on prognosis of young patients with breast cancer

  2018cites this paper
• The Epidemiological Challenges of Breast Cancer among Premenopausal Women in Limited Resource Settings.

  2017cites this paper
• Age, molecular subtypes and local therapy decision-making.

  2017cites this paper
• PALOMA-3: Phase III Trial of Fulvestrant With or Without Palbociclib in Premenopausal and Postmenopausal Women With Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer That Progressed on Prior Endocrine Therapy—Safety and Efficacy in Asian Patients

  2017cites this paper
• Molecular Biology In Young Women With Breast Cancer: From Tumor Gene Expression To DNA Mutations.

  2017cites this paper
• "Joven & Fuerte": Program for Young Women with Breast Cancer in Mexico - Initial Results.

  2017cites this paper
• Economic evaluation of sequencing strategies in HER2-positive metastatic breast cancer in Mexico: a contrast between public and private payer perspectives

  2017cites this paper